Steven Cohen’s Novartis NVS Stock Holding History

Steven Cohen’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.46M	Buy	54,000 +10,200	+23%	+$1.53M	0.01%	1389
2026 Q1	$6.69M	Buy	43,800 +4,900	+13%	+$751K	0.01%	1502
2025 Q4	$5.36M	Buy	38,900 +8,100	+26%	+$1.06M	0.01%	1792
2025 Q3	$3.95M	Hold	30,800	–	–	0.01%	1163
2025 Q2	$3.73M	Sell	30,800 -100,900	-77%	-$11.4M	0.01%	1064
2025 Q1	$14.7M	Buy	131,700 +100,900	+328%	+$10.7M	0.03%	542
2024 Q4	$3M	Buy	30,800 +100	+0.3%	+$10.7K	0.01%	1104
2024 Q3	$3.53M	Buy	+30,700	New	+$3.48M	0.01%	979
2024 Q1	–	Sell	-18,500	Closed	-$1.87M	–	2490
2023 Q4	$1.87M	Hold	18,500	–	–	﹤0.01%	1235
2023 Q3	$1.88M	Sell	18,500 -421,900	-96%	-$42.8M	0.01%	1140
2023 Q2	$44.4M	Buy	440,400 +421,900	+2,281%	+$42.2M	0.13%	196
2023 Q1	$1.7M	Buy	+18,500	New	+$1.62M	0.01%	1008

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Steven Cohen's NVS Position: Q2 2026 in Review

Steven Cohen reduced its Novartis (NVS) stake by 63% in Q2 2026, selling an estimated $26.6M and leaving 106,157 shares worth $16.6M. The position accounts for 0.02% of the portfolio, ranked #986.

Steven Cohen first reported a position in NVS in Q2 2014 and has held it in 23 quarters since. The position peaked at $167M in Q1 2023. 1,615 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Steven Cohen held 106,157 shares of Novartis worth $16.6M as of Q2 2026.
Steven Cohen sold 177,680 Novartis shares in Q2 2026, an estimated $26.6M.
Novartis made up 0.02% of Steven Cohen's portfolio in Q2 2026, its #986 holding.
Steven Cohen first reported a position in Novartis in Q2 2014 and has held it in 23 quarters since.
Steven Cohen's Novartis position peaked at $167M in Q1 2023.
1,615 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.